1. 32 Safety, pharmacokinetics and pharmacodynamics of BI 705564, a covalent inhibitor of brutons tyrosine kinase in phase 1 clinical trials in healthy volunteers. (April 2019) Authors: Litzenburger, Tobias; Müller, Fabian; Schultz, Armin; Klein, Elliott; Ramanujam, Meera; Wu, Jing; Wiebe, Sabrina; Benediktus, Ewald; Hui, Jianan; Li, Xiujiang; Flack, Mary; Padula, Steven J; Visvanathan, Sudha; Steffgen, Jürgen; Hünnemeyer, Andreas Journal: Lupus science & medicine Issue: Volume 6(2019)supplement 1 Page Start: A23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [P3–014]: INVESTIGATION OF PHARMACOKINETIC DRUG‐DRUG INTERACTION FOLLOWING ORAL ADMINISTRATION OF BI 409306 AND DONEPEZIL IN HEALTHY SUBJECTS. (1st July 2017) Authors: Wunderlich, Glen; Schultheis, Christian; Link, Jasmin; Schultz, Armin; Voelk, Claudia Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 19 Page Start: P935 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bioequivalence of macitentan and tadalafil given as fixed‐dose combination or single‐component tablets in healthy subjects. Issue 12 (29th May 2020) Authors: Grill, Simon; Bruderer, Shirin; Sidharta, Patricia N.; Antonova, Mariya; Globig, Susanne; Carlson, James; Schultz, Armin; Csonka, Dénes Journal: British journal of clinical pharmacology Issue: Volume 86:Issue 12(2020) Page Start: 2424 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Challenges in the Development of Intravenous Neurokinin‐1 Receptor Antagonists: Results of a Safety and Pharmacokinetics Dose‐Finding, Phase 1 Study of Intravenous Fosnetupitant. Issue 12 (20th October 2022) Authors: Tyler, Timothy; Schultz, Armin; Venturini, Alessio; Giuliano, Claudio; Bernareggi, Alberto; Spezia, Riccardo; Voisin, Daniel; Stella, Valentino Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 12(2022) Page Start: 1405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of faldaprevir on raltegravir pharmacokinetics in healthy volunteers. (8th December 2014) Authors: Joseph, David; Rose, Peter; Strelkowa, Natalja; Schultz, Armin; Garcia, Jeanette; Elgadi, Mabrouk; Huang, Fenglei Journal: Journal of clinical pharmacology Issue: Volume 55:Number 4(2015:Apr.) Page Start: 384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Midazolam microdosing applied in early clinical development for drug–drug interaction assessment. Issue 1 (10th June 2020) Authors: Wiebe, Sabrina T.; Huennemeyer, Andreas; Kadus, Werner; Goettel, Markus; Jambrecina, Alen; Schultz, Armin; Vinisko, Richard; Schlieker, Laura; Herich, Lena; Mikus, Gerd Journal: British journal of clinical pharmacology Issue: Volume 87:Issue 1(2021) Page Start: 178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P1‐061: Pharmacokinetics of Single and Multiple Rising Doses of BI 425809, A New Glyt1 Inhibitor, in Young and Elderly Healthy Volunteers. (1st July 2016) Authors: Moschetti, Viktoria; Schlecker, Christina; Schultz, Armin; Wind, Sven; Goetz, Sophia; Liesenfeld, Karl-Heinz; Schmitt, Holger; Mao, Yan; Ren, Bailuo; Wunderlich, Glen; Yum, Sun-Young A.; Desch, Michael Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2016)Part 8 Page Start: P425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pharmacokinetic Interaction between Faldaprevir and Cyclosporine or Tacrolimus in Healthy Volunteers: A Prospective, Open‐Label, Fixed‐Sequence, Crossover Study. Issue 1 (30th March 2018) Authors: Huang, Fenglei; Voelk, Claudia; Trampisch, Matthias; Rowland, Lois; Schultz, Armin; Sabo, John P. Journal: Basic & clinical pharmacology & toxicology Issue: Volume 123:Issue 1(2018) Page Start: 84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pharmacokinetics, Safety, and Tolerability of the Novel Chymase Inhibitor BAY 1142524 in Healthy Male Volunteers. Issue 4 (7th June 2018) Authors: Kanefendt, Friederike; Thuß, Uwe; Becka, Michael; Boxnick, Stefanie; Berse, Matthias; Schultz, Armin; Otto, Christiane Journal: Clinical pharmacology in drug development Issue: Volume 8:Issue 4(2019) Page Start: 467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pharmacokinetics, Safety, and Tolerability of the α2C‐Adrenoreceptor Antagonist BAY 1193397 in Healthy Male Subjects. Issue 3 (31st August 2021) Authors: Kapsa, Stefanie; Thuss, Uwe; Boxnick, Stefanie; Schaumann, Frank; Schultz, Armin; Unger, Sigrun; Otto, Christiane Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 3(2022) Page Start: 296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗